Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
Abstract
Prostate cancer is an androgen-driven tumor. Different prostate cancer therapies consequently focus on blocking the androgen receptor pathway. Clinical studies reported tumor resistance mechanisms by reactivating and bypassing the androgen pathway. Preclinical models allowed the identification, confirmation, and thorough study of these pathways. This review looks into the current and future role of preclinical models to understand resistance to...
Paper Details
Title
Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
Published Date
Feb 22, 2021
Journal
Volume
13
Issue
4
Pages
915 - 915
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History